Credit Suisse Downgrades Diplomat Pharmacy (DPLO) to Underperform on Slowing Organic Growth, Profit Challenges
Tweet Send to a Friend
Credit Suisse downgraded Diplomat Pharmacy (NYSE: DPLO) from Neutral to Underperform with a price target of $13.00 (from $18.00) on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
